K. Holdaway

发表

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer.

P. V. van Zijl, B. Baguley, G. Finlay, 1995, European Journal of Cancer.

Relationship of cell cycle parameters to in vitro and in vivo chemosensitivity for a series of Lewis lung carcinoma lines.

B. Baguley, G. Finlay, K. Holdaway, 1992, European journal of cancer.

Immuno-analysis of microparticles: probing at the limits of detection

N. Tiberti, Sharissa L. Latham, G. Grau, 2015, Scientific Reports.

Cytokinetic differences in the action ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin

B. Baguley, G. Finlay, A. Haldane, 2004, Cancer Chemotherapy and Pharmacology.

Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer

J. Jass, P. Browett, P. Jeevaratnam, 1995, The Lancet.

Growth of fetal thymocytes in organ culture: effect of recombinant lymphokines on thymocyte maturation.

J. Watson, P. Crosier, M. Skinner, 1989, Growth factors.

Anticancer drug sensitivity profiles of new and established melanoma cell lines.

B. Baguley, G. Finlay, E. Marshall, 1993, Oncology research.

Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine

L. Ferguson, B. Baguley, G. Whiteside, 1996, Environmental and molecular mutagenesis.

Comparison of the effects of genistein and amsacrine on leukemia cell proliferation.

B. Baguley, G. Finlay, K. Holdaway, 1994, Oncology research.

Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells

B. Baguley, G. Finlay, K. Holdaway, 2004, Cancer Chemotherapy and Pharmacology.

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism.

L. Thomsen, B. Baguley, L. J. Zwi, 1991, European journal of cancer.

An optimized whole blood method for flow cytometric measurement of ZAP‐70 protein expression in chronic lymphocytic leukemia

M. Forman, M. Keeney, P. Scibelli, 2006, Cytometry. Part B, Clinical cytometry.

Inhibition of growth of primary human tumour cell cultures by a 4-anilinoquinazoline inhibitor of the epidermal growth factor receptor family of tyrosine kinases.

W. Denny, G. Rewcastle, B. Baguley, 1998, European journal of cancer.

Annexin-V and TUNEL use in monitoring the progression of apoptosis in plants.

C. Reutelingsperger, I. O'brien, K. Holdaway, 1997, Cytometry.

Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment

G. Grau, P. Juillard, S. Byrne, 2020, Journal of Neuroimmunology.

Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cells.

M. Dragunow, B. Baguley, G. Finlay, 1997, European journal of cancer.

Modulation of Protein-DNA Interactions by Intercalating and Nonintercalating Agents

B. Baguley, G. Finlay, K. Holdaway, 1990 .

Design of NDA Intercalators To Overcome Topoisomerase II-Mediated Multidurg Resistance

B. Baguley, K. Holdaway, L. M. Frey, 1990 .

Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance.

B. Baguley, L. Fray, K. Holdaway, 1990, Journal of the National Cancer Institute.

Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays.

B. Baguley, G. Finlay, E. Marshall, 1994, European journal of cancer.

Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine

L. Ferguson, B. Baguley, G. Whiteside, 1996, Environmental and molecular mutagenesis.